Publicprivate partnership. This is 90 minutes. The subcommittee on space and aeronautics will come to order. Without objection the chair is authorized to declare recess on at any time. Welcome to todays hearing entitled returning to the moon, keeping artemis on track. I would like to acknowledge i appreciate the witnesses being here today. Mother nature is proving to be somewhat challenging this week as you can see by the turnout of membership. This has been hearing thats been much anticipated by the members in a very enthusiastic way, but you have to physically get here, and that is a challenge and the subcommittee chairman is in the air somewhere between here and houston, so the moment he arrives we will have a proper chairman to preside over this process. With that, i want to recognize myself for an opening statement. Good morning and welcome everyone to the science committees first hearing of 2024. Its fitting we are kicking off of the hearing on artemis given its importance to the
Back to gadgets . We will be live this hour. Betty a jampacked day today. You cannot get the bond kings to not talk today. This is noting that the 10 year, seemseasury bull market to become to an end and the bear market is starting with a yield and hitting 2. 5 and then you have jeffrey, coming out of the later, also in his outlook and webcast when he talks about bill gross saying that this might be a little early but with these yields rising, it is going to hurt u. S. Equities, he noted that everything about two point 63 is going to start hurting equities and that is why he sees the negative return in 2018. Heard that from a lot of the analysts we have heard talk to. But perhaps he jumped the gun when it comes to calling and confirming the end of that bowl, on the market. Bullbond market. It is going to be very interesting when it comes to the face income and currency. Lets see who is right we did see another day of record in tear, the s p , igher and as you can see all that is having
Sure its very important. That we have the appropriate people working. Im a big supporter of igs, and we take it seriously. We have implemented their recommendations. We have a personal Security Group now that ensures before an offer goes out if you have violated 1203b which are the two most serious issues you dont get hired. And if there are other conduct issues, not only are we going to follow the opm rules were going to review those for appropriateness for employment at the irs. People need to be comfortable that we take it seriously. And people working for the irs ought to be tax compliant. I appreciate that. And i would like the information on those that are still employed that came under these 824. The 824 covers a large a lot of the gentlemans time is expired. I recognize the gentleman from alabama, mr. Palmer, for five minutes. Thank you, mr. Chairman. I want to give mr. Koskanan a break here for a minute. I dont want you to think thats not appreciated. Well that doesnt mean i w
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual.
Marketresearch.biz reports that the global small molecule innovator CDMO market revenue is expected to increase to USD 84.7 Bn in 2032 from USD 45.4 Bn in 2022, and register a revenue CAGR of 6.6% during the forecast period (2023 to 2032).Overview of the Small Molecule Innovator CDMO MarketThe Small Molecule Innovat.